Texcell SA is a private company that provides viral safety and immunology services.
In 1987, as a service laboratory within the Pasteur Institute in Paris, Texcell started to evaluate the biosafety of biotech products: recombinant proteins, monoclonal antibodies, vaccines, medical devices and other products of human or animal origin (such as blood-derived products, heparin, hyaluronic acid and collagen).
In 1995, following improvements in gene therapy products, Texcell increased the range of tests offered and started biodistribution studies with patient monitoring.
In 2003, Texcell reinforced its patient follow-up studies by providing a new service - the ImmunoProfiling Lab - and Texcell SA, a Pasteur Institute spin-off, was founded.
In 2005, Texcell SA moved into new facilities in Evry Genopole, 30km south of Paris.
Our top priority is achievement of your goals:
- Customer satisfaction: today, the development time for a new molecule has to be as short as possible. Viral safety testing, viral clearance study and clinical studies need to be continually improved in order to optimize therapeutic strategies.
- Provision of the best services: Texcell mobilizes the people, protocols and tools needed to complete your project successfully.
- Guaranteed timelines: your dedicated project manager will provide a weekly progress report.
- Guaranteed quality: our quality department audits each study according GLP and GMP – Regulatory Agencies (AFSSAPS) and our clients audit our finality system regularly.
